{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T06:01:06Z","timestamp":1790316066717,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T00:00:00Z","timestamp":1428537600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12879-015-0910-3","type":"journal-article","created":{"date-parts":[[2015,4,8]],"date-time":"2015-04-08T14:32:14Z","timestamp":1428503534000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Severe morbidity after antiretroviral (ART) initiation: active surveillance in HIV care programs, the IeDEA West Africa collaboration"],"prefix":"10.1186","volume":"15","author":[{"name":"on behalf of the IeDEA West Africa Collaboration","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Abo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Zannou Djimon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eug\u00e8ne","family":"Messou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Balestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martial","family":"Kouakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"Akakpo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carin","family":"Ahouada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"de Rekeneire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Dabis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Lewden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Minga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,9]]},"reference":[{"key":"910_CR1","unstructured":"UNAIDS\/WHO. Global HIV\/AIDS response: Epidemic update and health sector progress towards Universal Access; Progress report 2011. Geneva: UNAIDS\/WHO; 2011. Available at: http:\/\/whqlibdoc.who.int\/publications\/2011\/9789241502986_eng.pdf . Accessed May, 4, 2012."},{"key":"910_CR2","unstructured":"World Health Organization. Towards Universal access: scaling up priority HIV\/AIDS interventions in the health sector. Progress report 2008. Geneva, Switzerland: World Health Organization; 2009. Available at : http:\/\/www.who.int\/hiv\/pub\/tuapr_2009_en.pdf . Accessed May, 5, 2009."},{"issue":"18","key":"910_CR3","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1097\/QAD.0b013e3282f09876","volume":"21","author":"R Moh","year":"2007","unstructured":"Moh R, Danel C, Messou E, Ouassa T, Gabillard D, Anzian A, et al. Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa. AIDS. 2007;21(18):2483\u201391.","journal-title":"AIDS"},{"issue":"11","key":"910_CR4","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1089\/aid.2006.0308","volume":"23","author":"C Seyler","year":"2007","unstructured":"Seyler C, Messou E, Gabillard D, Inwoley A, Alioum A, Anglaret X. Morbidity before and after HAART initiation in Sub-Saharan African HIV-infected adults: a recurrent event analysis. AIDS Res Hum Retroviruses. 2007;23(11):1338\u201347.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"910_CR5","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/QAI.0b013e3182821821","volume":"62","author":"G Delphine","year":"2013","unstructured":"Delphine G, Charlotte L, Ibra N, Raoul M, Olivier S, Besigin T-G, et al. Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1\u2013infected adults receiving antiretroviral therapy in Africa and Asia: Data From the ANRS 12222 Collaboration. J Acquir Immune Defic Syndr. 2013;62:555\u201361.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"15","key":"910_CR6","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1097\/QAD.0b013e32830007cd","volume":"22","author":"SD Lawn","year":"2008","unstructured":"Lawn SD, Harries AD, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2008;22(15):1897\u2013908.","journal-title":"AIDS"},{"issue":"4","key":"910_CR7","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1177\/135965350701200416","volume":"12","author":"E Losina","year":"2007","unstructured":"Losina E, Yazdanpanah Y, Deuffic-Burban S, Wang B, Wolf LL, Messou E, et al. The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Cote d\u2019Ivoire. Antivir Ther. 2007;12(4):543\u201351.","journal-title":"Antivir Ther"},{"key":"910_CR8","doi-asserted-by":"publisher","first-page":"18797","DOI":"10.7448\/IAS.17.1.18797","volume":"17","author":"C Lewden","year":"2014","unstructured":"Lewden C, Drabo YJ, Zannou DM, Maiga MY, Minta DK, Sow PS, et al. Disease patterns and causes of death of hospitalized HIV-positive adults in West Africa: a multicountry survey in the antiretroviral treatment era. J Int AIDS Soc. 2014;17:18797.","journal-title":"J Int AIDS Soc"},{"issue":"4","key":"910_CR9","doi-asserted-by":"publisher","first-page":"977","DOI":"10.4314\/ahs.v13i4.17","volume":"13","author":"AM Namutebi","year":"2013","unstructured":"Namutebi AM, Kamya MR, Byakika-Kibwika P. Causes and outcome of hospitalization among HIV-infected adults receiving antiretroviral therapy in Mulago hospital, Uganda. Afr Health Sci. 2013;13(4):977\u201385.","journal-title":"Afr Health Sci"},{"key":"910_CR10","first-page":"940580","volume":"2012","author":"D Ogoina","year":"2012","unstructured":"Ogoina D, Obiako RO, Muktar HM, Adeiza M, Babadoko A, Hassan A, et al. Morbidity and mortality patterns of hospitalised adult HIV\/AIDS patients in the Era of highly active antiretroviral therapy: a 4-year retrospective review from Zaria, Northern Nigeria. AIDS Res Treat. 2012;2012:940580.","journal-title":"AIDS Res Treat"},{"key":"910_CR11","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1186\/1471-2334-13-607","volume":"13","author":"Y Abo","year":"2013","unstructured":"Abo Y, Minga A, Menan H, Danel C, Ouassa T, Dohoun L, et al. Incidence of serious morbidity in HIV-infected adults on antiretroviral therapy in a West African care centre, 2003\u20132008. BMC Infect Dis. 2013;13:607.","journal-title":"BMC Infect Dis"},{"issue":"12","key":"910_CR12","doi-asserted-by":"publisher","first-page":"e83591","DOI":"10.1371\/journal.pone.0083591","volume":"8","author":"TD Moon","year":"2013","unstructured":"Moon TD, Silva WP, Buene M, Morais L, Valverde E, Vermund SH, et al. Bacteremia as a cause of fever in ambulatory, HIV-infected Mozambican adults: results and policy implications from a prospective observational study. PLoS One. 2013;8(12):e83591.","journal-title":"PLoS One"},{"key":"910_CR13","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/1471-2334-10-188","volume":"10","author":"PA Coffie","year":"2010","unstructured":"Coffie PA, Tonwe-Gold B, Tanon AK, Amani-Bosse C, Bedikou G, Abrams EJ, et al. Incidence and risk factors of severe adverse events with nevirapine-based antiretroviral therapy in HIV-infected women. MTCT-Plus program, Abidjan, Cote d\u2019Ivoire. BMC Infect Dis. 2010;10:188.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"910_CR14","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1089\/aid.2009.0309","volume":"26","author":"A Minga","year":"2010","unstructured":"Minga A, Lewden C, Dohoun L, Abo Y, Emieme A, Coulibaly A, et al. Short communication: Severe symptomatic hyperlactatemia among HIV type 1-infected adults on antiretroviral therapy in Cote d\u2019Ivoire. AIDS Res Hum Retroviruses. 2010;26(9):991\u20135.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"5","key":"910_CR15","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1177\/135965350501000510","volume":"10","author":"R Moh","year":"2005","unstructured":"Moh R, Danel C, Sorho S, Sauvageot D, Anzian A, Minga A, et al. Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in Cote d\u2019Ivoire. Antivir Ther. 2005;10(5):615\u201324.","journal-title":"Antivir Ther"},{"key":"910_CR16","doi-asserted-by":"crossref","unstructured":"Ali MK, Magee MJ, Dave JA, Ofotokun I, Tungsiripat M, Jones TK, et al. HIV and metabolic, body, and bone disorders: what we know from low- and middle-income countries. J Acquir Immune Defic Syndr. 2014;67 Suppl 1:S27\u201339.","DOI":"10.1097\/QAI.0000000000000256"},{"issue":"4","key":"910_CR17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/COH.0b013e3283479316","volume":"6","author":"DK Ekouevi","year":"2011","unstructured":"Ekouevi DK, Karcher S, Coffie PA. Strengthening health systems through HIV monitoring and evaluation in Sub-Saharan Africa. Curr Opin HIV AIDS. 2011;6(4):245\u201350.","journal-title":"Curr Opin HIV AIDS"},{"issue":"8","key":"910_CR18","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1097\/QAD.0b013e3283528ad4","volume":"26","author":"E Balestre","year":"2012","unstructured":"Balestre E, Eholie SP, Lokossue A, Sow PS, Charurat M, Minga A, et al. Effect of age on immunological response in the first year of antiretroviral therapy in HIV-1-infected adults in West Africa. AIDS. 2012;26(8):951\u20137.","journal-title":"AIDS"},{"issue":"Suppl 1","key":"910_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1365-3156.2010.02505.x","volume":"15","author":"DK Ekouevi","year":"2010","unstructured":"Ekouevi DK, Balestre E, Ba-Gomis FO, Eholie SP, Maiga M, Amani-Bosse C, et al. Low retention of HIV-infected patients on antiretroviral therapy in 11 clinical centres in West Africa. Trop Med Int Health. 2010;15 Suppl 1:34\u201342.","journal-title":"Trop Med Int Health"},{"key":"910_CR20","unstructured":"World Health Organization. Scaling up Antiretroviral therapy in resource-limited Settings: treatment Guidelines for a public heal thapproch (Revision 2003). Geneva; 2003. Available at: http:\/\/www.who.int\/hiv\/pub\/prev_care\/en\/arvrevision2003en.pdf . Accessed October, 11, 2012."},{"key":"910_CR21","unstructured":"World Health Organization. Antiretroviral Therapy For Hiv Infection In Adultsand Adolescents: Recommendationsfor a public health approach(2006 revision); 2006. Available at: http:\/\/www.who.int\/hiv\/pub\/guidelines\/artadultguidelines.pdf . Accessed January, 23, 2012."},{"key":"910_CR22","unstructured":"World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents:Recommendations for a public health approach (2010 version). 2010. Available at: http:\/\/whqlibdoc.who.int\/publications\/2010\/9789241599764_eng.pdf?ua=1596657_eng.pdf . Accessed January, 23, 2012."},{"key":"910_CR23","unstructured":"World Health Organization. Interim who clinical staging of HIV\/AIDS and hiv\/aids case definitions for surveillance. 2005. Available at: http:\/\/www.who.int\/hiv\/pub\/guidelines\/clinicalstaging.pdf . Accessed March, 1st, 2011."},{"key":"910_CR24","volume-title":"Echelle ANRS de cotation de la gravit\u00e9 des \u00e9v\u00e9nements ind\u00e9sirables graves chez l\u2019adulte. Version n\u00b06 du 9 septembre 2003 [Report on line]","author":"C Ton\u00e9atti","year":"2003","unstructured":"Ton\u00e9atti C, Bouxin-Metro A, Dormont J. Echelle ANRS de cotation de la gravit\u00e9 des \u00e9v\u00e9nements ind\u00e9sirables graves chez l\u2019adulte. Version n\u00b06 du 9 septembre 2003 [Report on line]. Paris: ANRS; 2003. Available at: http:\/\/www.anrs.fr\/Rubriques-transversales\/Outils-pour-la-recherche\/Pays-endeveloppement\/Preparer-la-recherche\/Declaration-des-evenements ."},{"key":"910_CR25","unstructured":"World Health Organization. International Statistical Classification of Diseases and Related Health Problems (ICD10), 10th revision, Volume 2 instruction manual, 2010 edition. Geneva: World Health Organization; 2010. Available at: http:\/\/www.who.int\/classifications\/icd\/ICD10Volume2_en_2010.pdf . Accessed July, 25, 2012."},{"key":"910_CR26","unstructured":"World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach; 2013. Available at: http:\/\/www.who.int\/hiv\/pub\/guidelines\/arv2013\/en\/index.html . Accessed July, 18, 2013."},{"issue":"1","key":"910_CR27","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1097\/QAI.0b013e3182a39979","volume":"65","author":"The IeDEA and ART cohort collaborations","year":"2014","unstructured":"The IeDEA and ART cohort collaborations. Immunodeficiency at the start of combination antiretroviral therapy in low-, middle- and high-income countries. J Acquir Immune Defic Syndr. 2014;65(1):e8\u201316.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"910_CR28","unstructured":"World Health Organization. WHO Global Malaria Program. World Malaria report 2011. Geneva; 2011. Available at: http:\/\/www.who.int\/malaria\/publications\/atoz\/9789241564403\/en\/index.html . Accessd August, 1st, 2013."},{"issue":"8","key":"910_CR29","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1093\/cid\/cis013","volume":"54","author":"JD Campbell","year":"2012","unstructured":"Campbell JD, Moore D, Degerman R, Kaharuza F, Were W, Muramuzi E, et al. HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells\/muL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea. Clin Infect Dis. 2012;54(8):1204\u201311.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"910_CR30","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/QAI.0000000000000304","volume":"67","author":"PE Brentlinger","year":"2014","unstructured":"Brentlinger PE, Silva WP, Buene M, Morais L, Valverde E, Vermund SH, et al. Management of fever in ambulatory HIV-infected adults in resource-limited settings: prospective observational evaluation of a New Mozambican guideline. J Acquir Immune Defic Syndr. 2014;67(3):304\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7476","key":"910_CR31","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1136\/bmj.38251.658229.55","volume":"329","author":"H Reyburn","year":"2004","unstructured":"Reyburn H, Mbatia R, Drakeley C, Carneiro I, Mwakasungula E, Mwerinde O, et al. Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. BMJ. 2004;329(7476):1212.","journal-title":"BMJ"},{"key":"910_CR32","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/1471-2334-10-179","volume":"10","author":"P Beaudrap De","year":"2010","unstructured":"De Beaudrap P, Etard JF, Diouf A, Ndiaye I, Ndeye GF, Sow PS, et al. Incidence and determinants of new AIDS-defining illnesses after HAART initiation in a Senegalese cohort. BMC Infect Dis. 2010;10:179.","journal-title":"BMC Infect Dis"},{"key":"910_CR33","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/1471-2334-9-205","volume":"9","author":"TK Cherif de","year":"2009","unstructured":"de Cherif TK, Schoeman JH, Cleary S, Meintjes GA, Rebe K, Maartens G. Early severe morbidity and resource utilization in South African adults on antiretroviral therapy. BMC Infect Dis. 2009;9:205.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"910_CR34","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1093\/cid\/cir898","volume":"54","author":"X Anglaret","year":"2012","unstructured":"Anglaret X, Minga A, Gabillard D, Ouassa T, Messou E, Morris B, et al. AIDS and non-AIDS morbidity and mortality across the spectrum of CD4 cell counts in HIV-infected adults before starting antiretroviral therapy in Cote d\u2019Ivoire. Clin Infect Dis. 2012;54(5):714\u201323.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"910_CR35","doi-asserted-by":"publisher","first-page":"e52019","DOI":"10.1371\/journal.pone.0052019","volume":"7","author":"AJ Curtis","year":"2012","unstructured":"Curtis AJ, Marshall CS, Spelman T, Greig J, Elliot JH, Shanks L, et al. Incidence of WHO stage 3 and 4 conditions following initiation of anti-retroviral therapy in resource limited settings. PLoS One. 2012;7(12):e52019.","journal-title":"PLoS One"},{"key":"910_CR36","unstructured":"World Health Organization. Investing in Health for Africa. The Case for Strengthening Systems for Better Health Outcomes. Geneva; 2011. Available at: http:\/\/www.who.int\/pmnch\/media\/membernews\/2011\/investing_health_africa_eng.pdf?ua=1 . Accessed October, 15, 2014."},{"issue":"6","key":"910_CR37","doi-asserted-by":"publisher","first-page":"e11213","DOI":"10.1371\/journal.pone.0011213","volume":"5","author":"A Beauliere","year":"2010","unstructured":"Beauliere A, Toure S, Alexandre PK, Kone K, Pouhe A, Kouadio B, et al. The financial burden of morbidity in HIV-infected adults on antiretroviral therapy in Cote d\u2019Ivoire. PLoS One. 2010;5(6):e11213.","journal-title":"PLoS One"},{"issue":"4","key":"910_CR38","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2471\/BLT.07.049643","volume":"87","author":"S Boyer","year":"2009","unstructured":"Boyer S, Marcellin F, Ongolo-Zogo P, Abega SC, Nantchouang R, Spire B, et al. Financial barriers to HIV treatment in Yaounde, Cameroon: first results of a national cross-sectional survey. Bull World Health Organ. 2009;87(4):279\u201387.","journal-title":"Bull World Health Organ"},{"key":"910_CR39","volume-title":"L\u2019assurance maladie en Afrique francophone: am\u00e9liorer l\u2019acc\u00e8s aux soins et lutter contre la pauvret\u00e9","year":"2006","unstructured":"Dussault G, Fournier P, Letourmy A, editors. L\u2019assurance maladie en Afrique francophone: am\u00e9liorer l\u2019acc\u00e8s aux soins et lutter contre la pauvret\u00e9. Washington, DC: The World Bank; 2006."},{"issue":"Suppl 2","key":"910_CR40","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.1097\/QAD.0b013e32835bdde6","volume":"26","author":"P Munderi","year":"2012","unstructured":"Munderi P, Grosskurth H, Droti B, Ross DA. What are the essential components of HIV treatment and care services in low and middle-income countries: an overview by settings and levels of the health system? AIDS. 2012;26 Suppl 2:S97\u2013103.","journal-title":"AIDS"},{"issue":"Suppl 2","key":"910_CR41","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.1097\/QAD.0b013e32835bde37","volume":"26","author":"DA Ross","year":"2012","unstructured":"Ross DA, South A, Weller I, Hakim J. HIV treatment and care systems: the way forward. AIDS. 2012;26 Suppl 2:S147\u201352.","journal-title":"AIDS"},{"key":"910_CR42","unstructured":"UNAIDS. UNAIDS World AIDS Day Report 2012. Geneva; 2012. Available at: http:\/\/www.unaids.org\/en\/media\/unaids\/contentassets\/documents\/epidemiology\/2012\/gr2012\/JC2434_WorldAIDSday_results_en.pdf . Accessed December 10, 2014."},{"key":"910_CR43","unstructured":"World Health Organization. WHO consultation on technical and operational recommendations for scale-up of laboratory services and monitoring HIV antiretroviral therapy in resource-limited settings; 2004. Available at: http:\/\/www.who.int\/diagnostics_laboratory\/LabMeetingDec_2004.PDF?ua=1 . Accessed January 20, 2015."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-015-0910-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0910-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0910-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0910-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T16:08:29Z","timestamp":1651680509000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-015-0910-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,9]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["910"],"URL":"https:\/\/doi.org\/10.1186\/s12879-015-0910-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,9]]},"article-number":"176"}}